Skip to main content
. 2021 Jun 28;13(13):3230. doi: 10.3390/cancers13133230

Figure 4.

Figure 4

Metabolic activities/metabolites and the associated noninvasive techniques for their assessment with diagnostic, therapy selection and efficacy prospects. (A). PET-based detection of infused 18FDG. (B). PET-based detection of infused 18FGln. (C). PET-based detection of infused 11CAc. (D). MRS-based detection of infused 2HG. (E). MRI-based detection of 13C-Lactate produced from infused hyperpolarized 1-13C-pyruvate. (F). MRI-based detection of 13C-2HG produced from infused hyperpolarized 1-13C-glutamine. (G). LC-MS-based detection of circulating (D-)2HG. (H). LC-MS-based detection of circulating tryptophan and kynurenine. 18FDG: 18F-2-deoxyglucose; 18FGln: 4-18F-(2S,4R)-fluoroglutamine; 11CAc: 1-11C-acetate; ACSS2: acetyl-CoA synthetase 2; IDO1: indoleamine 2,3 dioxygenase 1; TDO2: tryptophan-2,3-dioxygenase 2.